Facebook Linkedin RSS Twitter Youtube
Home 2025

Merck

Seven Biopharma Trends to Watch in 2025
GEN Edge

Seven Biopharma Trends to Watch in 2025

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics
Artificial Intelligence

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors
Drug Discovery

StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors

Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space
Drug Discovery

Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Artificial Intelligence

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate

Amgen Opts-in on Generate:Biomedicines Collaboration for Drug Development
Artificial Intelligence

Amgen Opts-in on Generate:Biomedicines Collaboration for Drug Development

Salt Burn: NFX and Merck Seed Pepper Bio to Develop Drugs with Transomics
Artificial Intelligence

Salt Burn: NFX and Merck Seed Pepper Bio to Develop Drugs with Transomics

Emerging Infectious Diseases Prompt a Layered Response
Infectious Diseases

Emerging Infectious Diseases Prompt a Layered Response

Biopharma Collaboration: Roadmap Towards the Facility of the Future
Bioprocessing

Biopharma Collaboration: Roadmap Towards the Facility of the Future

Collaborating for Filtration Success, Virtually
News

Collaborating for Filtration Success, Virtually

12Page 1 of 2
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.